Resumen
This document provides region-specific information for:
— local submissions and approvals for vascular device-drug combination products (VDDCPs) in countries and regions around the world;
— changes related to the drug-containing part and how they are evaluated by different local regions.
For implanted products, this document is considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
This document is considered also as a supplement to ISO 12417-1, and any relevant device-specific standards, such as the ISO 25539 series specifying requirements for endovascular devices. This document also addresses VDDCPs that are not necessarily permanent implants.
Informaciones generales
-
Estado: PublicadoFecha de publicación: 2022-07Etapa: Norma Internacional publicada [60.60]
-
Edición: 2Número de páginas: 29
-
Comité Técnico :ISO/TC 150/SC 2ICS :11.040.40
- RSS actualizaciones
Ciclo de vida
-
Anteriormente
RetiradaISO/TR 12417-2:2017
-
Ahora